glp-1 compounding crackdown news october 2025 The FDA announced plans to take action against non-FDA-approved receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded semaglutide (Wegovy) weight-loss pill from the 503A GLP-1 Compounding Compliance, Trends,
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
























